Literature DB >> 20160354

Surgery for gastric cancer: an evidence-based perspective.

Melroy A D'souza1, Kailash Singh, Shailesh V Shrikhande.   

Abstract

Despite a decreasing incidence, stomach cancer is the second leading cause of cancer mortality worldwide. Surgical resection offers the only chance for cure in this aggressive cancer. The surgical management of gastric cancer has witnessed numerous debates in the past decades. These include the extent of lymphadenectomy, extent of surgery, role of laparoscopic gastrectomy, and the impact of high volume of centers, on the outcome of surgery. This review attempts to address these controversies with an evidence-based perspective. A literature search in MEDLINE (www.pubmed.org) has been performed with the relevant key words and corresponding MeSH terms. The search has been limited to English publications on human subjects. A manual search of the bibliographies has also been carried out, to identify the relevant publications for possible inclusion.

Entities:  

Mesh:

Year:  2009        PMID: 20160354     DOI: 10.4103/0973-1482.59891

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  7 in total

1.  Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer.

Authors:  Giuseppe Verlato; Simone Giacopuzzi; Maria Bencivenga; Paolo Morgagni; Giovanni De Manzoni
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

2.  Short-Term Outcome in Patients Undergoing Gastrectomy with D2 Lymphadenectomy for Carcinoma Stomach.

Authors:  Ganesh Vadthya; Vishnu Prasad Nelamangala Ramakrishnaiah; Srinivasan Krishnamachari
Journal:  Indian J Surg Oncol       Date:  2017-02-13

Review 3.  Management of gastric cancer in Indian population.

Authors:  Mohammed Ibrahim; Kissan Gilbert
Journal:  Transl Gastroenterol Hepatol       Date:  2017-08-09

4.  Histological evaluation for chemotherapeutic responses of metastatic lymph nodes in gastric cancer.

Authors:  Osamu Kinoshita; Daisuke Ichikawa; Yusuke Ichijo; Shuhei Komatsu; Kazuma Okamoto; Mitsuo Kishimoto; Akio Yanagisawa; Eigo Otsuji
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

5.  Gastric cancer in India.

Authors:  Atul Sharma; Venkatraman Radhakrishnan
Journal:  Indian J Med Paediatr Oncol       Date:  2011-01

6.  D2 lymphadenectomy is not only safe but necessary in the era of neoadjuvant chemotherapy.

Authors:  Shailesh V Shrikhande; Savio G Barreto; Sanjay D Talole; Kumar Vinchurkar; Somashekar Annaiah; Kunal Suradkar; Shaesta Mehta; Mahesh Goel
Journal:  World J Surg Oncol       Date:  2013-02-02       Impact factor: 2.754

7.  Clinical implications of DLL4 expression in gastric cancer.

Authors:  Sumiya Ishigami; Takaaki Arigami; Yoshikazu Uenosono; Hiroshi Okumura; Hiroshi Kurahara; Yasuto Uchikado; Tetsuro Setoyama; Yoshiaki Kita; Yuko Kijima; Yuka Nishizono; Akihiro Nakajo; Tetsuro Owaki; Shinichi Ueno; Shoji Natsugoe
Journal:  J Exp Clin Cancer Res       Date:  2013-07-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.